PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
25-Feb-2025 Galapagos to Present at Upcoming Investor Conferences Galapagos
25-Feb-2025 BioMarin Announces Appointment of Timothy P. Walbert to Board of Directors BioMarin
25-Feb-2025 AMYRA Publishes Landmark Review Supporting New Gluten Digestion Approach for Celiac Disease AMYRA Biotech
24-Feb-2025 Scottish bio-tech company secures £3.4m investment uFraction8
24-Feb-2025 Cresset releases Flare™ V10, the latest update to its agile ligand and structure-based drug design platform, Cresset
21-Feb-2025 Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC Tiziana Life Sciences
21-Feb-2025 Next-gen Biomanufacturing Market Size | USD 39.4 Bn & 7.5% Growth TechWire24
21-Feb-2025 PharmaBlock Launches Commercial GMP Workshop 503 at Zhejiang Site PharmaBlock
20-Feb-2025 Novadip shares positive 12-month results from phase 1b/2a trial with NVDX3 in trauma Andrew Lloyd Associates
19-Feb-2025 Illumina unveils first-of-its-kind spatial transcriptomics technology Illumina
19-Feb-2025 Isomerase Strengthens Leadership Team by Appointing Three New Associate Directors Isomerase
19-Feb-2025 Ona Therapeutics Strengthens Leadership Team to Accelerate First-in-Class ADCs into Clinical Development Across Cancer Types Ona Therapeutics
19-Feb-2025 Protheragen-ING Offers a Full Range of Nonsteroidal Anti-inflammatory APIs, Including Celecoxib and Crisaborole Protheragen-ING
18-Feb-2025 Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program Tiziana Life Sciences
18-Feb-2025 LoQus23 Therapeutics appoints Cyrus Mozayeni MD to Chair of the Board of Directors LoQus23 Therapeutics Ltd
18-Feb-2025 AlgoTx Announces Results of its Phase 2 “ACT” Trial of ATX01 in Chemotherapy-Induced Peripheral Neuropathy AlgoTherapeutix (AlgoTx)
18-Feb-2025 Creative Proteomics Expands Services to Include Comprehensive Analysis of Short Chain Fatty Acids Creative Proteomics
18-Feb-2025 Creative Proteomics Launches Comprehensive Ames Test Service to Enhance Mutagenicity Testing Creative Proteomics
14-Feb-2025 Protheragen-ING's AI-Synthesizer Helps to Streamline the Synthesis of Small Molecule Drugs Protheragen-ING
14-Feb-2025 Navigating FDA 510(k) Approval with Proregulations' Services Proregulations